Literature DB >> 11141645

Ocular complications of topical, peri-ocular, and systemic corticosteroids.

M C Carnahan1, D A Goldstein.   

Abstract

Topical ophthalmic, oral, and intravenous corticosteroids have long been associated with ocular side effects. Recent data suggest that inhaled corticosteroids are also associated with the development of cataract and increased intraocular pressure. Thus far, nasally administered steroids have not been associated with the same effects. Local injection of steroids, even at sites far from the eye, have been associated with the development of cataract, glaucoma, and even retinal and choroidal emboli. Any physician prescribing corticosteroids should be aware of these potential ocular side effects and should advise patients accordingly.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11141645     DOI: 10.1097/00055735-200012000-00016

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  79 in total

Review 1.  Locally administered ocular corticosteroids: benefits and risks.

Authors:  Charles N J McGhee; Simon Dean; Helen Danesh-Meyer
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  Bilateral acute depigmentation of the iris first misdiagnosed as acute iridocyclitis.

Authors:  Altan Goktas; Sertan Goktas
Journal:  Int Ophthalmol       Date:  2011-06-03       Impact factor: 2.031

3.  Glucocorticoids in the treatment of early and late RA.

Authors:  J W J Bijlsma; M Boers; K G Saag; D E Furst
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

4.  Epidemiology and molecular analysis of herpes simplex keratitis requiring primary penetrating keratoplasty.

Authors:  B C Branco; P A Gaudio; T P Margolis
Journal:  Br J Ophthalmol       Date:  2004-10       Impact factor: 4.638

Review 5.  Corticosteroid treatment of periorbital haemangioma of infancy: a review of the evidence.

Authors:  T M Ranchod; I J Frieden; D R Fredrick
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

Review 6.  Strategies for minimizing corticosteroid toxicity: a review.

Authors:  Roosy Aulakh; Surjit Singh
Journal:  Indian J Pediatr       Date:  2008-11-21       Impact factor: 1.967

7.  Long-term stability of uveitis with faint anterior chamber flare treated with once-daily topical ophthalmic betamethasone.

Authors:  Masahide Kawamura; Masahiro Zako
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

8.  Rimexolone 1% versus prednisolone acetate in preventing early postoperative inflammation after cataract surgery.

Authors:  Sevim Kavuncu; Hasan Horoz; Aylin Ardagil; Hasan H Erbil
Journal:  Int Ophthalmol       Date:  2007-08-31       Impact factor: 2.031

9.  Analysis of the prevalence of cataracts and glaucoma in systemic lupus erythematosus and evaluation of the rheumatologists' practice for the monitoring of glucocorticoid eye toxicity.

Authors:  L Carli; C Tani; F Querci; A Della Rossa; S Vagnani; C Baldini; R Talarico; A d'Ascanio; R Neri; A G Tavoni; S Bombardieri; M Mosca
Journal:  Clin Rheumatol       Date:  2013-03-03       Impact factor: 2.980

Review 10.  Current and emerging therapies for corneal neovascularization.

Authors:  Danial Roshandel; Medi Eslani; Alireza Baradaran-Rafii; Albert Y Cheung; Khaliq Kurji; Sayena Jabbehdari; Alejandra Maiz; Setareh Jalali; Ali R Djalilian; Edward J Holland
Journal:  Ocul Surf       Date:  2018-06-20       Impact factor: 5.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.